Trial intelligence / Profile preview

Testosterone for Myocardial Ischaemia in Men with CHD

NCT00239590Phase 2Completed

Sponsor
Imperial College London
Start
Jun 2001
Primary completion
Apr 2004
Modality
Hormone, Biologic
Countries
1
01

Overview

A Phase 2 trial of testosterone undecanoate in coronary heart disease (CHD), sponsored by Imperial College London. Started Jun 2001; status: completed.

02

Drugs

testosterone undecanoate
03

Conditions

coronary heart disease (CHD)

Beyond the preview

Go deeper on NCT00239590.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00239590.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call